Baxter Healthcare recall: Cefazolin in Dextrose
Baxter Healthcare Corporation is recalling Cefazolin in Dextrose – 19,032 bags. The U.S. Food and Drug Administration published the recall on August 19, 2026; it began on July 24, 2026. Distributed nationwide.
Most serious Class I is the most serious level: a reasonable probability that using or eating the product will cause serious health problems or death.

Share
| Product | Cefazolin in Dextrose |
| Brand | Baxter Healthcare |
| Company | Baxter Healthcare Corporation |
| Type | Drugs |
| Classification | Class I |
| Recall date | July 24, 2026 |
| Published by FDA | August 19, 2026 |
| Quantity | 19,032 bags |
| Recall ID | 99463 |
Recalled products
- Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
- FDA recall number
- D-0787-2026
- Codes, lots and dates
- Lot # LD175708, Exp Date: 14-Feb-2027.
- Quantity
- 19,032 bags
- Classification
- Class I
Identifiers and details
- FDA event ID
- 99463
- Initiated
- Voluntary: Firm initiated
- Status
- Ongoing
- Firm location
- Deerfield, IL, United States
Why it was recalled
The reason the FDA lists: “Presence of Particulate Matter”
Where it was sold
Nationwide. Distribution as the FDA records it: “US Nationwide.”
What to do
Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.
Official notice: FDA Enforcement Report record (event 99463, openFDA) – the same recall numbers can be searched in the FDA Enforcement Report.
Other Baxter Healthcare recalls
| Date | Recall | Problem | Agency |
|---|---|---|---|
| Sep 30, 2026 | Contamination within the release test equipment flow path could have affected the accuracy… Serious | FDA Class II | |
| Sep 30, 2026 | There is an error in the product description on the Unique Device Identification (UDI) lab… Serious | FDA Class II | |
| Sep 16, 2026 | Presence of Particulate Matter: particulate matter identified as stainless steel particles… Most serious | FDA Class I | |
| Sep 9, 2026 | Presence of particulate matter: Particulates identified as fiberglass Most serious | FDA Class I | |
| Sep 9, 2026 | A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a s… Serious | FDA Class II | |
| Sep 9, 2026 | manufacturing-practice violations Serious | FDA Class II | |
| Aug 19, 2026 | Baxter received customer reports of air bubbles in the drip chamber and tubing when a pres… Most serious | FDA Class I |
All 8 Baxter Healthcare recalls →
About this recall
Is Baxter Healthcare Cefazolin in Dextrose recalled?
Yes. Baxter Healthcare Corporation recalled it on July 24, 2026; FDA published it August 19, 2026 (Class I). Only the lots, dates or models listed on this page are included.
Why was it recalled?
Presence of Particulate Matter
What should I do if I have it?
Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.
Where was it sold?
Nationwide.
More recalls
Source: recall records published by the U.S. Food and Drug Administration (openFDA Enforcement Reports), the USDA Food Safety and Inspection Service, the Consumer Product Safety Commission and the National Highway Traffic Safety Administration, collected twice a day. Product names, lot codes, dates and model numbers are shown exactly as the agency lists them; the agency's notice is the authority. 77.today is not affiliated with any of these agencies.